Description

We collaborate with several laboratories in developing new retinol derivatives that are more enhanced than existing Retinol in respects to function and stability. Developing the skills to produce high value-added Retinol from low-cost materials, we devote all our energy towards cutting the cost of production considerably and to become more efficient than the existing synthesis method. We have acquired the genes to develop new mass production methods. We are researching the conditions of production and enzyme biosynthesis. Having already completed the derivative improved stability, we will commence clinical testing. Working out the strategy of total R&D, we are collaborating consistently in developing excellent new derivatives with the ultimate goal of specialization in the field of Retinol.